SEC Form D private-offering filing

Telo Genomics Corp.

Name: Telo Genomics Corp. - new SEC Form D private-offering filing, Vancouver, BC, Canada
Published: 2026-04-24

A new SEC Form D private-offering notice from Vancouver, BC, Canada, a $19,100 filer-stated offering target in Biotech. The source filing is one click away.

Telo Genomics Corp. site↗ Verified via SEC Form D

Biotechnology company developing a telomere based diagnostic and prognostic platform for cancer and neurological disease, based in Vancouver, British Columbia.

Filed 2026-04-24Filed to raise $19,100First money in 2026-03-06Raised so far $7,346HQ (as filed) Vancouver, BC, CanadaSector Biotech ✓Stage (inferred) Pre-seedCall status Non-US principal office

Source linked the Form D on EDGAR↗Website verified telodx.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.